search
Back to results

Burst Spinal Cord Stimulation for Neuropathic Pain

Primary Purpose

Neuropathic Pain

Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
dorsal column stimulator
Sponsored by
University Hospital, Antwerp
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neuropathic Pain focused on measuring tonic, burst and placebo stimulation

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

All patients were selected after multidisciplinary discussion with a specialized pain physician, a psychological and psychiatric evaluation was performed to rule out psychogenic pain as well as other psychiatric morbidity contraindicating an implant. After authorization by the psychologist and psychiatrist an implant was offered.

Inclusion Criteria

  • Patients enrolled in this study must meet the following inclusion criteria:
  • Patients able to provide informed consent to participate in the study;
  • Patient is between the age of 18 and 75;
  • Patient has Failed Back Surgery Syndrome;
  • Patient has a simulator implanted at the dorsal column spinal cord powered by an EON/EON Mini® internal pulse generator.
  • Patient medication has remained stable for at least 4 weeks prior to baseline data collection;
  • Patient agrees not to add or increase medication throughout the randomization trial period of the study;
  • Patient is willing to cooperate with the study requirements including compliance with the treatment regimen and completion of all office visits.

Exclusion Criteria

A patient will be excluded from participation in this study if they meet any one of the following criteria:

  • Patient has current evidence of any psychiatric disorder, as documented by the DSM-IV-TR criteria with psychotic characteristics;
  • Patient has a history of life-threatening severe illness or is suffering from severe chronic disease other than the indication for the study;
  • Patient has history of substance abuse or substance dependency in the past 6 months prior to baseline data collection;
  • Patient currently participating in another clinical study;
  • Patient with demand-type cardiac pacemakers, an infusion pump or any other implantable neurostimulator device except for the spinal cord stimulator under study;
  • Patient is not willing to maintain current medication regimen;
  • Female candidates of child bearing potential who are pregnant (confirmed by positive urine/blood pregnancy test), not using adequate contraception as determined by the investigator, or nursing (lactating) a child.

Sites / Locations

  • University Hospital Antwerp

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Tonic

Sham

burst

Arm Description

5 hz stimulation at an amplitude that the patient find bearable (+/- 1.5 mA)

no stimulation, patient receive a sham stimulation (actually the IPG is not running)

500 hz burst at 5 hz stimulation

Outcomes

Primary Outcome Measures

Visual Analogue Scales for pain back, pain limb, pain general and paresthesia

Secondary Outcome Measures

VAS scores for pain now, worst pain, least pain and pain vigilance and awareness questionnaire

Full Information

First Posted
September 21, 2011
Last Updated
December 2, 2011
Sponsor
University Hospital, Antwerp
search

1. Study Identification

Unique Protocol Identification Number
NCT01486108
Brief Title
Burst Spinal Cord Stimulation for Neuropathic Pain
Official Title
Burst, Tonic and Sham Spinal Cord Stimulation. A Verification of the Best Treatment Protocol
Study Type
Interventional

2. Study Status

Record Verification Date
December 2011
Overall Recruitment Status
Completed
Study Start Date
January 2011 (undefined)
Primary Completion Date
August 2011 (Actual)
Study Completion Date
September 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Antwerp

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Recently a novel stimulation design was developed, called burst stimulation. In a non-placebo controlled pilot study burst stimulation seemed superior to tonic stimulation over a period extending more than 2 years, and even though an incidental finding, this design seemed capable of suppressing pain without mandatory induction of paresthesias. This permits for the first time to scientifically prove that spinal cord stimulation is better than placebo stimulation. A study was therefore initiated to find out whether spinal cord stimulation is indeed capable of suppressing neuropathic limb pain in a placebo controlled way.
Detailed Description
Patients receive three type of stimulation (burst, tonic and sham). We want to compare these different stimulation protocol to verify which one is the one the patient prefer the most and have the least side-effects (paresthesia)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuropathic Pain
Keywords
tonic, burst and placebo stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
15 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tonic
Arm Type
Experimental
Arm Description
5 hz stimulation at an amplitude that the patient find bearable (+/- 1.5 mA)
Arm Title
Sham
Arm Type
Experimental
Arm Description
no stimulation, patient receive a sham stimulation (actually the IPG is not running)
Arm Title
burst
Arm Type
Experimental
Arm Description
500 hz burst at 5 hz stimulation
Intervention Type
Procedure
Intervention Name(s)
dorsal column stimulator
Other Intervention Name(s)
IPG is used by ST Jude medical together with an 88 lamitrode lead
Intervention Description
test different settings of stimulation
Primary Outcome Measure Information:
Title
Visual Analogue Scales for pain back, pain limb, pain general and paresthesia
Secondary Outcome Measure Information:
Title
VAS scores for pain now, worst pain, least pain and pain vigilance and awareness questionnaire

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
All patients were selected after multidisciplinary discussion with a specialized pain physician, a psychological and psychiatric evaluation was performed to rule out psychogenic pain as well as other psychiatric morbidity contraindicating an implant. After authorization by the psychologist and psychiatrist an implant was offered. Inclusion Criteria Patients enrolled in this study must meet the following inclusion criteria: Patients able to provide informed consent to participate in the study; Patient is between the age of 18 and 75; Patient has Failed Back Surgery Syndrome; Patient has a simulator implanted at the dorsal column spinal cord powered by an EON/EON Mini® internal pulse generator. Patient medication has remained stable for at least 4 weeks prior to baseline data collection; Patient agrees not to add or increase medication throughout the randomization trial period of the study; Patient is willing to cooperate with the study requirements including compliance with the treatment regimen and completion of all office visits. Exclusion Criteria A patient will be excluded from participation in this study if they meet any one of the following criteria: Patient has current evidence of any psychiatric disorder, as documented by the DSM-IV-TR criteria with psychotic characteristics; Patient has a history of life-threatening severe illness or is suffering from severe chronic disease other than the indication for the study; Patient has history of substance abuse or substance dependency in the past 6 months prior to baseline data collection; Patient currently participating in another clinical study; Patient with demand-type cardiac pacemakers, an infusion pump or any other implantable neurostimulator device except for the spinal cord stimulator under study; Patient is not willing to maintain current medication regimen; Female candidates of child bearing potential who are pregnant (confirmed by positive urine/blood pregnancy test), not using adequate contraception as determined by the investigator, or nursing (lactating) a child.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sven Vanneste, PhD
Organizational Affiliation
Universiteit Antwerpen
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Antwerp
City
Edegem
ZIP/Postal Code
2650
Country
Belgium

12. IPD Sharing Statement

Citations:
PubMed Identifier
34854473
Citation
O'Connell NE, Ferraro MC, Gibson W, Rice AS, Vase L, Coyle D, Eccleston C. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev. 2021 Dec 2;12(12):CD013756. doi: 10.1002/14651858.CD013756.pub2.
Results Reference
derived

Learn more about this trial

Burst Spinal Cord Stimulation for Neuropathic Pain

We'll reach out to this number within 24 hrs